|
G |
Esr2 |
estrogen receptor 2 |
|
IMP |
|
RGD |
PMID:29580824 |
RGD:38548925 |
NCBI chr 6:100,589,553...100,645,240
|
|
G |
Esr2em1Soar |
estrogen receptor 2; ZFN induced mutant 1, Soar |
|
IMP |
compared to wild type |
RGD |
PMID:29580824 |
RGD:38548925 |
|
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
NCBI chr 3:67,370,794...67,452,422
|
|
G |
Dpp4DPPIV |
dipeptidylpeptidase 4; DPPIV mutant |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
|
|
|
G |
Cfb |
complement factor B |
|
IMP |
compared to wild type SHR |
RGD |
PMID:28739975 |
RGD:127285403 |
NCBI chr20:3,970,643...3,976,510
|
|
G |
Cfbem1Tja |
complement factor B, ZFN induced mutant 1, Tja |
|
IMP |
compared to wild type SHR |
RGD |
PMID:28739975 |
RGD:127285403 |
|
|
G |
Kcnj16 |
potassium inwardly-rectifying channel, subfamily J, member 16 |
|
IMP |
compared to SS/JrHsdMcwi |
RGD |
PMID:28931751 |
RGD:38500204 |
NCBI chr10:96,489,329...96,520,745
|
|
G |
Kcnj16em1Mcwi |
potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin |
|
IMP |
compared to SS/JrHsdMcwi |
RGD |
PMID:28931751 |
RGD:38500204 |
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
IMP |
|
RGD |
PMID:34256052 |
RGD:405878088 |
NCBI chr 6:57,961,423...57,998,901
|
|
G |
Ahrem1Soar |
aryl hydrocarbon receptor; CRISPR/Cas9 induced mutant1, Soar |
|
IMP |
|
RGD |
PMID:34256052 |
RGD:405878088 |
|
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
NCBI chr 3:67,370,794...67,452,422
|
|
G |
Dpp4DPPIV |
dipeptidylpeptidase 4; DPPIV mutant |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
|
|
G |
Tspo |
translocator protein |
induces |
IMP |
|
RGD |
PMID:29074640 |
RGD:150429771 |
NCBI chr 7:116,600,214...116,610,461
|
|
G |
Tspoem1Vpl |
translocator protein; ZFN induced mutant1, Vpl |
induces |
IMP |
|
RGD |
PMID:29074640 |
RGD:150429771 |
|
|
G |
Tspoem2Vpl |
translocator protein; ZFN induced mutant2, Vpl |
induces |
IMP |
|
RGD |
PMID:29074640 |
RGD:150429771 |
|
|
|
G |
Crh |
corticotropin releasing hormone |
|
IDA |
|
RGD |
PMID:12450317 |
RGD:704424 |
NCBI chr 2:104,059,184...104,061,048
|
|
G |
Esr2 |
estrogen receptor 2 |
|
IMP |
|
RGD |
PMID:28520870 |
RGD:38548924 |
NCBI chr 6:100,589,553...100,645,240
|
|
G |
Esr2em1Soar |
estrogen receptor 2; ZFN induced mutant 1, Soar |
|
IMP |
|
RGD |
PMID:28520870 |
RGD:38548924 |
|
|
|
G |
Esr2 |
estrogen receptor 2 |
|
IMP |
|
RGD |
PMID:28520870 |
RGD:38548924 |
NCBI chr 6:100,589,553...100,645,240
|
|
G |
Esr2em1Soar |
estrogen receptor 2; ZFN induced mutant 1, Soar |
|
IMP |
|
RGD |
PMID:28520870 |
RGD:38548924 |
|
|
G |
Wwox |
WW domain-containing oxidoreductase |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 |
RGD:150429974 |
NCBI chr19:59,338,402...60,269,323
|
|
G |
Wwoxlde |
WW domain-containing oxidoreductase; lde mutant |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 |
RGD:150429974 |
|
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
|
IMP |
DNA:missense mutation:cds:nucleotide 1027 |
RGD |
PMID:27129673 |
RGD:150520013 |
NCBI chr 2:110,268,489...110,271,865
|
|
G |
Ghsrm1Mcwi |
growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin |
|
IMP |
compared to wild type rats in response to ghrelin (CHEBI:75431) |
RGD |
PMID:27129673 |
RGD:150520013 |
|
|
|
G |
Gja8 |
gap junction protein, alpha 8 |
|
IAGP |
|
RGD |
PMID:27871290 |
RGD:150429989 |
NCBI chr 2:184,490,840...184,492,456
|
|
G |
Gja8m1Cub |
gap junction protein, alpha 8; mutant 1 Cub |
|
IAGP |
|
RGD |
PMID:27871290 |
RGD:150429989 |
|
|
G |
Tbc1d1 |
TBC1 domain family member 1 |
induces |
IMP |
compared to Wild type |
RGD |
PMID:28177704 |
RGD:150521607 |
NCBI chr14:44,289,241...44,489,246
|
|
G |
Tbc1d1Tn(sb)1Fkh |
TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh |
induces |
IMP |
compared to Wild type |
RGD |
PMID:28177704 |
RGD:150521607 |
|
|
|
G |
Cftr |
CF transmembrane conductance regulator |
|
IMP |
|
RGD |
PMID:29190650 |
RGD:151347176 |
NCBI chr 4:47,422,084...47,694,646
|
|
G |
Cftrem1Sage |
cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage |
|
IMP |
|
RGD |
PMID:29190650 |
RGD:151347176 |
|
|
|
G |
Bscl2 |
BSCL2 lipid droplet biogenesis associated, seipin |
|
IMP |
|
RGD |
PMID:25934999 |
RGD:11085488 |
NCBI chr 1:205,731,828...205,743,430
|
|
G |
Bscl2m1Kyo |
BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo |
|
IMP |
|
RGD |
PMID:25934999 |
RGD:11085488 |
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
|
IMP |
|
RGD |
PMID:19931319 |
RGD:12910109 |
NCBI chr 2:110,268,489...110,271,865
|
|
G |
Pmch |
pro-melanin-concentrating hormone |
|
IMP |
compared to wild-type |
RGD |
PMID:23555928 PMID:19934402 |
RGD:150429944, RGD:150429945 |
NCBI chr 7:22,511,934...22,513,250
|
|
G |
Pmchm1Hubr |
pro-melanin-concentrating hormone; ENU induced mutant1, Hubr |
|
IMP |
compared to wild-type |
RGD |
PMID:23555928 PMID:19934402 |
RGD:150429944, RGD:150429945 |
|
|
|
G |
Tg |
thyroglobulin |
|
IAGP |
|
RGD |
PMID:10760744 |
RGD:13605608 |
NCBI chr 7:98,418,293...98,603,210
|
|
G |
Tgrdw |
thyroglobulin; rdw mutant |
|
IAGP |
|
RGD |
PMID:10760744 |
RGD:13605608 |
|
|
|
G |
Esr2 |
estrogen receptor 2 |
|
IMP |
|
RGD |
PMID:28520870 |
RGD:38548924 |
NCBI chr 6:100,589,553...100,645,240
|
|
G |
Esr2em1Soar |
estrogen receptor 2; ZFN induced mutant 1, Soar |
|
IMP |
|
RGD |
PMID:28520870 |
RGD:38548924 |
|
|
G |
Kiss1 |
KiSS-1 metastasis-suppressor |
|
IMP |
|
RGD |
PMID:25582792 |
RGD:10059342 |
NCBI chr13:44,775,106...44,780,707
|
|
G |
Kiss1tm1Nips |
KiSS-1 metastasis-suppressor; targeted mutant 1, Nips |
|
IMP |
|
RGD |
PMID:25582792 |
RGD:10059342 |
|
|
G |
Wwox |
WW domain-containing oxidoreductase |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 |
RGD:150429974 |
NCBI chr19:59,338,402...60,269,323
|
|
G |
Wwoxlde |
WW domain-containing oxidoreductase; lde mutant |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 |
RGD:150429974 |
|
|
|
G |
Crh |
corticotropin releasing hormone |
|
IDA |
|
RGD |
PMID:12450317 |
RGD:704424 |
NCBI chr 2:104,059,184...104,061,048
|
|
G |
Esr2 |
estrogen receptor 2 |
|
IMP |
|
RGD |
PMID:29580824 |
RGD:38548925 |
NCBI chr 6:100,589,553...100,645,240
|
|
G |
Esr2em1Soar |
estrogen receptor 2; ZFN induced mutant 1, Soar |
|
IMP |
compared to wild type |
RGD |
PMID:29580824 |
RGD:38548925 |
|
|
|
G |
Lrrk2 |
leucine-rich repeat kinase 2 |
|
IMP |
|
RGD |
PMID:23799078 |
RGD:13462048 |
NCBI chr 7:124,706,246...124,867,234
|
|
G |
Lrrk2em1Sage |
leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:23799078 |
RGD:13462048 |
|
|
|
G |
Dhh |
desert hedgehog signaling molecule |
|
IMP |
|
RGD |
PMID:21062903 |
RGD:38548923 |
NCBI chr 7:130,050,910...130,056,406
|
|
G |
Tspo |
translocator protein |
|
IMP |
|
RGD |
PMID:29074640 |
RGD:150429771 |
NCBI chr 7:116,600,214...116,610,461
|
|
G |
Tspoem1Vpl |
translocator protein; ZFN induced mutant1, Vpl |
|
IMP |
|
RGD |
PMID:29074640 |
RGD:150429771 |
|
|
G |
Tspoem2Vpl |
translocator protein; ZFN induced mutant2, Vpl |
|
IMP |
|
RGD |
PMID:29074640 |
RGD:150429771 |
|
|
G |
Wwox |
WW domain-containing oxidoreductase |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 |
RGD:150429974 |
NCBI chr19:59,338,402...60,269,323
|
|
G |
Wwoxlde |
WW domain-containing oxidoreductase; lde mutant |
|
IAGP |
compared to wild type and heterozygotes |
RGD |
PMID:18676360 |
RGD:150429974 |
|
|
|
G |
Tshr |
thyroid stimulating hormone receptor |
|
IMP |
|
RGD |
PMID:29507327 |
RGD:150521601 |
NCBI chr 6:116,072,321...116,206,009
|
|
G |
Tshrem1Mlit |
thyroid stimulating hormone receptor; CRISPR/Cas9 induced mutant 1, Mlit |
|
IMP |
|
RGD |
PMID:29507327 |
RGD:150521601 |
|
|
|
G |
Tshr |
thyroid stimulating hormone receptor |
|
IMP |
|
RGD |
PMID:29507327 |
RGD:150521601 |
NCBI chr 6:116,072,321...116,206,009
|
|
G |
Tshrem1Mlit |
thyroid stimulating hormone receptor; CRISPR/Cas9 induced mutant 1, Mlit |
|
IMP |
|
RGD |
PMID:29507327 |
RGD:150521601 |
|
|
|
G |
Gh1 |
growth hormone 1 |
|
IAGP |
|
RGD |
PMID:2152867 |
RGD:1578506 |
NCBI chr10:91,727,883...91,729,860
|
|
G |
Gh1sdr |
|
|
IAGP |
|
RGD |
PMID:2152867 |
RGD:1578506 |
|
|
|
G |
Gh1 |
growth hormone 1 |
|
IAGP |
|
RGD |
PMID:2152867 |
RGD:1578506 |
NCBI chr10:91,727,883...91,729,860
|
|
G |
Gh1sdr |
|
|
IAGP |
|
RGD |
PMID:2152867 |
RGD:1578506 |
|
|
|
G |
Pax6 |
paired box 6 |
|
IAGP |
DNA:frameshift mutation:cds: |
RGD |
PMID:21203536 |
RGD:8552339 |
NCBI chr 3:92,128,772...92,157,022
|
|
G |
Pax6Sey2 |
paired box gene 6, small eye mutation 2 |
|
IAGP |
|
RGD |
PMID:21203536 |
RGD:8552339 |
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
|
IMP |
|
RGD |
PMID:19246633 |
RGD:4889487 |
NCBI chr10:62,322,688...62,357,060
|
|
|
G |
Ctns |
cystinosin, lysosomal cystine transporter |
|
IMP |
|
RGD |
PMID:35695380 |
RGD:155630629 |
NCBI chr10:58,300,069...58,315,725
|
|
|
G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
IAGP |
|
RGD |
PMID:11832364 |
RGD:727991 |
NCBI chr 7:108,719,349...108,726,024
|
|
|
G |
Cyp11b2 |
cytochrome P450, family 11, subfamily b, polypeptide 2 |
|
IAGP |
|
RGD |
PMID:11832364 |
RGD:727991 |
NCBI chr 7:108,719,349...108,726,024
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
sexual_dimorphism |
IMP |
compared to female wild type littermate |
RGD |
PMID:31329100 |
RGD:407571699 |
NCBI chr18:31,522,783...31,644,508
|
|
G |
Nr3c1em1Kuan |
nuclear receptor subfamily 3, group C, member 1; CRISPR/Cas9 induced mutant1, Kuan |
sexual_dimorphism |
IMP |
compared to female wild type littermate |
RGD |
PMID:31329100 |
RGD:407571699 |
|
|
G |
Nrg1 |
neuregulin 1 |
|
IMP |
DNA:transposon insertion |
RGD |
PMID:21092742 |
RGD:10449008 |
NCBI chr16:65,954,084...67,007,484
|
|
G |
Nrg1Tn(sb-T2/Bart3)2.183Mcwi |
neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin |
|
IMP |
compared to wild-type |
RGD |
PMID:21092742 |
RGD:10449008 |
|
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
IMP |
in KO rat |
RGD |
PMID:30893315 |
RGD:126908018 |
NCBI chr 4:169,491,273...169,496,500
|
|
G |
Cdkn1bem1Musc |
cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc |
|
IMP |
at 9 weeks |
RGD |
PMID:30893315 |
RGD:126908018 |
|
|
G |
Cdkn1bem4Musc |
cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc |
|
IMP |
at 9 weeks |
RGD |
PMID:30893315 |
RGD:126908018 |
|
|
|
G |
Esr1 |
estrogen receptor 1 |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
NCBI chr 1:43,511,685...43,904,454
|
|
G |
Esr1em1Soar |
estrogen receptor 1; ZFN induced mutant 1, Soar |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
|
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
NCBI chr 3:67,370,794...67,452,422
|
|
G |
Dpp4DPPIV |
dipeptidylpeptidase 4; DPPIV mutant |
|
IAGP |
compared to DA/Ztm |
RGD |
PMID:19327106 |
RGD:41408336 |
|
|
|
G |
Bscl2 |
BSCL2 lipid droplet biogenesis associated, seipin |
|
IMP |
|
RGD |
PMID:25934999 |
RGD:11085488 |
NCBI chr 1:205,731,828...205,743,430
|
|
G |
Bscl2m1Kyo |
BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo |
|
IMP |
|
RGD |
PMID:25934999 |
RGD:11085488 |
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
|
IMP |
compared to wild type |
RGD |
PMID:29656108 |
RGD:150520032 |
NCBI chr 5:116,295,691...116,323,219
|
|
G |
Cyp2j4em1Sage |
cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage |
|
IMP |
compared to wild type |
RGD |
PMID:29656108 |
RGD:150520032 |
|
|
G |
Gja8 |
gap junction protein, alpha 8 |
|
IAGP |
|
RGD |
PMID:27871290 |
RGD:150429989 |
NCBI chr 2:184,490,840...184,492,456
|
|
G |
Gja8m1Cub |
gap junction protein, alpha 8; mutant 1 Cub |
|
IAGP |
|
RGD |
PMID:27871290 |
RGD:150429989 |
|
|
G |
Insr |
insulin receptor |
induced |
IMP |
|
RGD |
PMID:19017805 |
RGD:2314405 |
NCBI chr12:5,991,135...6,129,275
|
|
G |
Lepr |
leptin receptor |
|
IMP IAGP |
DNA:mutations:cds: : (rat) |
RGD |
PMID:27465994 PMID:28746409 |
RGD:12911217, RGD:401965413 |
NCBI chr 5:121,409,735...121,593,201
|
|
G |
Leprem2Mcwi |
leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin |
|
IMP |
|
RGD |
PMID:27465994 |
RGD:12911217 |
|
|
G |
Mc4r |
melanocortin 4 receptor |
|
IMP |
|
RGD |
PMID:24400148 |
RGD:13825242 |
NCBI chr18:62,689,798...62,691,685
|
|
G |
Mc4rm1Hubr |
melanocortin 4 receptor; ENU induced mutation 1, Hubr |
|
IMP |
|
RGD |
PMID:24400148 |
RGD:13825242 |
|
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
|
IAGP |
|
RGD |
PMID:14724732 |
RGD:737686 |
NCBI chr 2:93,488,251...93,492,961
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
IMP |
|
RGD |
PMID:28469073 |
RGD:12910100 |
NCBI chr 8:20,270,020...20,292,981
|
|
G |
Ldlrem1Sage |
low density lipoprotein receptor; ZFN induced mutant 1, Sage |
|
IMP |
|
RGD |
PMID:28469073 |
RGD:12910100 |
|
|
G |
Lepr |
leptin receptor |
|
IMP IAGP |
compared to lean littermates |
RGD |
PMID:27465994 PMID:9032111 |
RGD:12911217, RGD:11570540 |
NCBI chr 5:121,409,735...121,593,201
|
|
G |
Leprcp |
leptin receptor;corpulent |
|
IAGP |
compared to lean littermates |
RGD |
PMID:9032111 |
RGD:11570540 |
|
|
G |
Leprem2Mcwi |
leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin |
|
IMP |
|
RGD |
PMID:27465994 |
RGD:12911217 |
|
|
G |
Leprfa |
leptin receptor; fa mutant |
|
IAGP |
compared to lean littermates |
RGD |
PMID:9032111 |
RGD:11570540 |
|
|
G |
Mc4r |
melanocortin 4 receptor |
|
IMP |
|
RGD |
PMID:21527895 PMID:24400148 |
RGD:6478803, RGD:13825242 |
NCBI chr18:62,689,798...62,691,685
|
|
G |
Mc4rm1Hubr |
melanocortin 4 receptor; ENU induced mutation 1, Hubr |
|
IMP |
|
RGD |
PMID:21527895 PMID:24400148 |
RGD:6478803, RGD:13825242 |
|
|
|
G |
Esr1 |
estrogen receptor 1 |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
NCBI chr 1:43,511,685...43,904,454
|
|
G |
Esr1em1Soar |
estrogen receptor 1; ZFN induced mutant 1, Soar |
|
IMP |
|
RGD |
PMID:24506075 |
RGD:8552987 |
|
|
G |
Lrrk2 |
leucine-rich repeat kinase 2 |
|
IMP |
|
RGD |
PMID:23799078 |
RGD:13462048 |
NCBI chr 7:124,706,246...124,867,234
|
|
G |
Lrrk2em1Sage |
leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:23799078 |
RGD:13462048 |
|
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
treatment |
IMP |
compared to Jcl:Wi and treated |
RGD |
PMID:32231239 |
RGD:32716373 |
NCBI chr 7:64,756,626...64,761,570
|
|
G |
Cyp27b1em1Thka |
cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka |
treatment |
IMP |
compared to Jcl:Wi and treated |
RGD |
PMID:32231239 |
RGD:32716373 |
|
|
G |
Vdr |
vitamin D receptor |
treatment |
IMP |
compared to Jcl:Wi and treated |
RGD |
PMID:32231239 PMID:32231239 |
RGD:32716373, RGD:32716373 |
NCBI chr 7:130,864,764...130,916,757
|
|
G |
Vdrem1Thka |
vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka |
treatment |
IMP |
compared to Jcl:Wi and treated |
RGD |
PMID:32231239 |
RGD:32716373 |
|
|
G |
Vdrem2Thka |
vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka |
|
IMP |
|
RGD |
PMID:32231239 |
RGD:32716373 |
|
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
IMP |
at 4-6 weeks |
RGD |
PMID:30893315 |
RGD:126908018 |
NCBI chr 4:169,491,273...169,496,500
|
|
G |
Cdkn1bem1Musc |
cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc |
|
IMP |
at 4-6 weeks |
RGD |
PMID:30893315 |
RGD:126908018 |
|
|
G |
Cdkn1bem4Musc |
cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc |
|
IMP |
at 4-6 weeks |
RGD |
PMID:30893315 |
RGD:126908018 |
|
|
|
G |
Lrrk2 |
leucine-rich repeat kinase 2 |
|
IMP |
|
RGD |
PMID:23799078 |
RGD:13462048 |
NCBI chr 7:124,706,246...124,867,234
|
|
|
G |
Tshr |
thyroid stimulating hormone receptor |
|
IMP |
|
RGD |
PMID:29507327 |
RGD:150521601 |
NCBI chr 6:116,072,321...116,206,009
|
|
G |
Tshrem1Mlit |
thyroid stimulating hormone receptor; CRISPR/Cas9 induced mutant 1, Mlit |
|
IMP |
|
RGD |
PMID:29507327 |
RGD:150521601 |
|
|
|
G |
Park7 |
Parkinsonism associated deglycase |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
NCBI chr 5:166,636,551...166,659,825
|
|
G |
Park7em1Sage |
parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
|
|
G |
Pink1 |
PTEN induced kinase 1 |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
NCBI chr 5:155,813,838...155,825,950
|
|
G |
Pink1em1Sage |
PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs |
|
IMP |
|
RGD |
PMID:24969022 |
RGD:13210569 |
|
|
|
G |
Tg |
thyroglobulin |
|
IAGP |
|
RGD |
PMID:10760744 |
RGD:13605608 |
NCBI chr 7:98,418,293...98,603,210
|
|
G |
Tgrdw |
thyroglobulin; rdw mutant |
|
IAGP |
|
RGD |
PMID:10760744 |
RGD:13605608 |
|
|